Jason A. Carter

Jason A. Carter

Auto-generated profile, based on publicly available information

Jason A. Carter

Department of Surgery, University of Washington, Seattle, Washington

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
SDSheela Damle
Sheela Damle
JCJason A. Carter
Jason A. Carter
KGKristin E. Goodsell
Kristin E. Goodsell
JPJose M.B. Pineda
Jose M.B. Pineda
LDLindsay K. Dickerson
Lindsay K. Dickerson
VPVenu Pillarisetty
Venu Pillarisetty
Effective antitumor immunity ultimately depends on the priming and activation of tumor-specific cytotoxic CD8+ T cells; however, the role of intratumoral cell–cell immune interactions remains incompletely understood. Recent work has revealed that the temporospatial co-localization of dendritic cells (DC), T helper (Th) cells, and cytotoxic T lymphocytes (CTL) within the tumor immune microenvironment following immune checkpoint blockade correlates with clinical response. In this study, we report the integration of more than 1 million spatially resolved single-cell profiles across six spatial proteomic and transcriptomic assays, which demonstrated that DC:Th:CTL three-cell-type clusters were common even in immunotherapy-naïve and highly desmoplastic tumors, such as fibrolamellar carcinoma and pancreatic ductal adenocarcinoma. We found that these immune triads were enriched for functionally important type 1 conventional DC, mature DCs enriched in immunoregulatory molecules, CXCL13+ Th, and GZMK+ effector CTL phenotypes. Subsequent multiplex immunofluorescence imaging of more than 450 primary pancreatic ductal adenocarcinoma tumors showed that the density of antigen-presenting cell:Th:CTL three-cell-type clusters was correlated with intratumoral T-cell clonal expansion and improved overall survival. These findings suggest that DC:Th:CTL triads are conserved across solid tumors and highlight the importance of intratumoral spatial niches in mediating endogenous antitumor immunity.

3 February 2026
Verified
Other
Open access
SDSheela Damle
Sheela Damle
JCJason A. Carter
Jason A. Carter
KGKristin E. Goodsell
Kristin E. Goodsell
JPJose M.B. Pineda
Jose M.B. Pineda
LDLindsay K. Dickerson
Lindsay K. Dickerson
VPVenu Pillarisetty
Venu Pillarisetty
Supplemental Table S3. Characteristics for PDAC patients undergoing upfront resection included in the Xenium Prime dataset

3 February 2026
Verified
Other
Open access
SDSheela Damle
Sheela Damle
JCJason A. Carter
Jason A. Carter
KGKristin E. Goodsell
Kristin E. Goodsell
JPJose M.B. Pineda
Jose M.B. Pineda
LDLindsay K. Dickerson
Lindsay K. Dickerson
VPVenu Pillarisetty
Venu Pillarisetty
Supplemental Figure S2. KPC tumor cell types.

3 February 2026
Verified
Other
Open access
SDSheela Damle
Sheela Damle
JCJason A. Carter
Jason A. Carter
KGKristin E. Goodsell
Kristin E. Goodsell
JPJose M.B. Pineda
Jose M.B. Pineda
LDLindsay K. Dickerson
Lindsay K. Dickerson
VPVenu Pillarisetty
Venu Pillarisetty
Supplemental Table S2. FLC patient characteristics

3 February 2026
Verified
Other
Open access
SDSheela Damle
Sheela Damle
JCJason A. Carter
Jason A. Carter
KGKristin E. Goodsell
Kristin E. Goodsell
JPJose M.B. Pineda
Jose M.B. Pineda
LDLindsay K. Dickerson
Lindsay K. Dickerson
VPVenu Pillarisetty
Venu Pillarisetty
Supplemental Figure S8. Identification of cell types in PDAC tissue microarray.

3 February 2026
Verified
Other
Open access
SDSheela Damle
Sheela Damle
JCJason A. Carter
Jason A. Carter
KGKristin E. Goodsell
Kristin E. Goodsell
JPJose M.B. Pineda
Jose M.B. Pineda
LDLindsay K. Dickerson
Lindsay K. Dickerson
VPVenu Pillarisetty
Venu Pillarisetty
Supplemental Table S4. PDAC tissue microarray patient characteristics